References
- Nathwani B. N., Rappaport H., Moran E. M., Pangalis G. A., Kim H. Malignant lymphoma arising in angioimmunoblastic lymphadenopathy. Cancer 1978; 41: 578–607
- Zulman J., Jaffe R., Talal N. Evidence that the malignant lymphoma of Sjogren's syndrome is a monoclonal B-cell neoplasm. N. Engl. J. Med. 1978; 229: 1215–1220
- Gleichmann E., Van Elven F., Gleichmann S. Immunoblastic lymphadenopathy, systemic lupus erythematosis and related disorders. Am. J. Clin. Pathol. 1979; 72: 708–723
- Pirofsky B. Autoimmune hemolytic anemia and neo-plasia of the reticuloendothelium. Ann. Intern. Med. 1968; 68: 109–121
- Kaden S. B. R., Rosse W. F., Hauch T. W. Immune thrombocytopenia in lymphoproliferative diseases. Blood 1979; 53: 545–551
- Carey R. W., McGinnis A., Jacobson B. M., Carvalho A. Idiopathic thrombocytopenic purpura complicating chronic lymphocytic leukemia. Management with sequential splenectomy and chemotherapy. Arch. Intern. Med. 1976; 136: 62–66
- Jones S. E. Autoimmune disorders and malignant lymphoma. Cancer 1973; 31: 1092–1098
- Miller D. G. The association of immune disease and malignant lymphoma. Ann. Intern. Med. 1967; 66: 507–521
- Le Tourneau A., Audouin J., Garbe L., Capron F., Servais B., Monges G., Payan H., Diebold J. Primary pulmonary malignant lymphoma, clinical and pathological findings, immunohistochemical and ultrastructural studies in 15 cases. Hematol. Oncol. 1983; 1: 49–60
- Schwartz K. A., Slichter S. J., Marker L. A. Immune mediated platelet destruction and thrombocytopenia in patients with solid tumors. Br. J. Haematol. 1982; 51: 17–24
- Rai K. R., Sawitsky A., Cronkite E. P., Chanana A. D., Levy R. N., Pasternack B. S. Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219–234
- McMillan R. Chronic idiopathic thrombocytopenic purpura. N. Engl. J. Med. 1981; 304: 1135–1147
- Trent R. J., Clancy R. L., Danis V., Basten A. Disodered immune homeostasis in chronic idiopathic thrombocytopenic purpura. Clinical and Experimental Immunology 1981; 45: 9–17
- Robert F., Maria T. F., Mirella G., Paolo L., Gabriello B., Margherita B., Guido F. Immunoregulatory T-cell defects in B-cell chronic lymphocytic leukemia cause or consequence of the disease? The contributory role of decreased availability of interleukin 2. Blood Celis 1987; 12: 399–412
- Wolos J. A., Davey F. R. B-lymphocyte function in B-cell chronic lymphocytic leukemia. Br. J. Haematol. 1981; 49: 395–403
- Isakovic K., Lenert G. Reactivity of B leukemic lymphocytes of patients with chronic lymphocytic leukemia to PWM and PHA. Blood cells 1987; 12: 355–364
- Johnstone A. P., Millard R. E., Hudson L. The roles of leukemic and residual normal cells in the proliferative response of chronic lymphocytic leukemic lymphoctyes to mitogens. Clin. Exp. Immunol. 1982; 47: 689–696
- Umadone H, Uchiyama T., Onishi R., Hori T., Uchino H., Nesumi N. Leukemic cells from chronic T lymphocytic leukemia patient proliferated in response to both interleukin-2 and interleukin-4 without prior stimulation and produced intcrleukin-2 mRNA with stimulation. Blood 1988; 72: 1177–1181